Multiple Micronutrient Versus Iron-Folic Acid Supplementation in Pregnant Women in Indonesia
Effect of Multiple Micronutrient Supplementation Versus Iron and Folic Acid Supplementation on Maternal Nutritional Biomarkers and Birth Outcomes Among Pregnant Women in Indonesia
1 other identifier
interventional
66
1 country
1
Brief Summary
Micronutrient deficiencies during pregnancy may affect the mother's nutritional status and the baby's growth. This study compared two types of daily supplements for pregnant women: a multiple micronutrient supplement and an iron and folic acid supplement. Pregnant women in Indonesia who were at 12 weeks of gestation or earlier were randomly assigned to receive one of the two supplements for eight weeks. The study measured maternal body weight, mid-upper arm circumference, hemoglobin concentration, and serum zinc concentration before and after supplementation. Infant birth weight and the occurrence of low birth weight were assessed after delivery. The purpose of the study was to determine whether multiple micronutrient supplementation produced greater improvements in maternal nutritional indicators and birth outcomes than iron and folic acid supplementation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2026
CompletedFirst Submitted
Initial submission to the registry
July 21, 2026
CompletedFirst Posted
Study publicly available on registry
July 24, 2026
CompletedJuly 24, 2026
July 1, 2026
6 months
July 21, 2026
July 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Maternal Body Weight
Change in maternal body weight calculated as the value measured after eight weeks of supplementation minus the baseline value, expressed in kilograms.
Baseline and 8 weeks
Change in Maternal Mid-Upper Arm Circumference
Change in maternal mid-upper arm circumference calculated as the value measured after eight weeks of supplementation minus the baseline value, expressed in centimeters.
Baseline and 8 weeks
Change in Maternal Hemoglobin Concentration
Change in maternal hemoglobin concentration calculated as the value measured after eight weeks of supplementation minus the baseline value, expressed in g/dL. Time Frame:
Baseline and 8 weeks
Study Arms (2)
Multiple Micronutrient Supplementation
EXPERIMENTALParticipants assigned to this arm received one multiple micronutrient supplement daily for eight weeks.
Iron and Folic Acid Supplementation
ACTIVE COMPARATORParticipants assigned to this arm received one iron and folic acid supplement daily for eight weeks according to the applicable antenatal supplementation standard.
Interventions
One tablet was administered orally once daily for eight weeks.
One tablet was administered orally once daily for eight weeks.
Eligibility Criteria
You may qualify if:
- Pregnant women at 12 weeks of gestation or earlier Aged 18 to 40 years No diagnosed chronic disease Willing to complete all study procedures Provided written informed consent
You may not qualify if:
- Severe pregnancy complications Known allergy to any supplement ingredient Inability to communicate adequately with the research team Planned relocation from the study area within the following six months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Puskesmas Grobogan
Purwodadi Grobogan, Central Java, 90222, Indonesia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer and Principal Investigator
Study Record Dates
First Submitted
July 21, 2026
First Posted
July 24, 2026
Study Start
July 10, 2025
Primary Completion
December 25, 2025
Study Completion
April 10, 2026
Last Updated
July 24, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because the informed consent obtained from participants did not include permission for sharing individual-level data with external researchers.